Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Breast Neoplasms
Interventions
DRUG

exemestane

take orally one tablet per day of exemestane 25 mg and one tablet per day of anastrozole placebo daily after meal

DRUG

anastrozole

take orally one tablet of anastrozole 1 mg and one tablet of exemestane placebo daily after meal

Trial Locations (47)

Unknown

Pfizer Investigational Site, Toyohashi

Pfizer Investigational Site, Anjo

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Toyoake

Pfizer Investigational Site, Toyota

Pfizer Investigational Site, Chiba

Pfizer Investigational Site, Sakura

Pfizer Investigational Site, Matsuyama

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Kitakyushu

Pfizer Investigational Site, Kurume

Pfizer Investigational Site, Kōriyama

Pfizer Investigational Site, Ōta

Pfizer Investigational Site, Hiroshima

Pfizer Investigational Site, Kure

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Akashi

Pfizer Investigational Site, Amagasaki

Pfizer Investigational Site, Kobe

Pfizer Investigational Site, Higashiibaraki-gun

Pfizer Investigational Site, Hitachi

Pfizer Investigational Site, Morioka

Pfizer Investigational Site, Kagoshima

Pfizer Investigational Site, Sagamihara

Pfizer Investigational Site, Yokohama

Pfizer Investigational Site, Kumamoto

Pfizer Investigational Site, Sendai

Pfizer Investigational Site, Niigata

Pfizer Investigational Site, Kurashiki

Pfizer Investigational Site, Naha

Pfizer Investigational Site, Osaka

Pfizer Investigational Site, Sakai

Pfizer Investigational Site, Iruma-gun

Pfizer Investigational Site, Kita-adachi-gun

Pfizer Investigational Site, Saitama

Pfizer Investigational Site, Hamamatsu

Pfizer Investigational Site, Shizuoka

Pfizer Investigational Site, Sunto-gun

Pfizer Investigational Site, Shimotsuke

Pfizer Investigational Site, Utsunomiya

Pfizer Investigational Site, Bunkyo-ku

Pfizer Investigational Site, Chiyoda-ku

Pfizer Investigational Site, Chuo-Ku

Pfizer Investigational Site, Koto-ku

Pfizer Investigational Site, Meguro-ku

Pfizer Investigational Site, Mitaka

Pfizer Investigational Site, Chiba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00143390 - Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer | Biotech Hunter | Biotech Hunter